Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Benner

Showing results (241-250 of 347) with videos related to

Pageof 35
Sort By:
Haematologica|October 2, 2010
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myelomaDirk Hose, Thierry Rème, Thomas Hielscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN lociStefan Pfister, Marc Remke, Axel Benner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromesAndrea Pellagatti, Axel Benner, Ken I Mills, et al.
Frontiers in Immunology|May 19, 2023
Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantationMarie Luise Hütter-Krönke, Adela Neagoie, Igor Wolfgang Blau, et al.
Cancer Letters|December 19, 2015
Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cellsTaronish D Dubash, Christopher M Hoffmann, Felix Oppel, et al.
Annals of Surgical Oncology|August 11, 2012
Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapyChristoph Kahlert, Eva Gaitzsch, Gunnar Steinert, et al.
British Journal of Haematology|March 19, 2016
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trialElias K Mai, Axel Benner, Uta Bertsch, et al.
Cancer Research|August 18, 2011
Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapyNiels Halama, Sara Michel, Matthias Kloor, et al.
Blood|January 26, 2017
Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemiaTilmann Bochtler, Martin Granzow, Friedrich Stölzel, et al.
The Lancet. Oncology|October 5, 2019
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort studyCarmen D Herling, Kevin R Coombes, Axel Benner, et al.
Pageof 35

Showing results (241-250 of 347) with videos related to

Sort By:
Pageof 35
Haematologica|October 2, 2010
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myelomaDirk Hose, Thierry Rème, Thomas Hielscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN lociStefan Pfister, Marc Remke, Axel Benner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromesAndrea Pellagatti, Axel Benner, Ken I Mills, et al.
Frontiers in Immunology|May 19, 2023
Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantationMarie Luise Hütter-Krönke, Adela Neagoie, Igor Wolfgang Blau, et al.
Cancer Letters|December 19, 2015
Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cellsTaronish D Dubash, Christopher M Hoffmann, Felix Oppel, et al.
Annals of Surgical Oncology|August 11, 2012
Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapyChristoph Kahlert, Eva Gaitzsch, Gunnar Steinert, et al.
British Journal of Haematology|March 19, 2016
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trialElias K Mai, Axel Benner, Uta Bertsch, et al.
Cancer Research|August 18, 2011
Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapyNiels Halama, Sara Michel, Matthias Kloor, et al.
Blood|January 26, 2017
Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemiaTilmann Bochtler, Martin Granzow, Friedrich Stölzel, et al.
The Lancet. Oncology|October 5, 2019
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort studyCarmen D Herling, Kevin R Coombes, Axel Benner, et al.
Pageof 35